A Defined, Plant-Based Diet and Other Integrative Therapies Improve Functional Status and Ejection Fraction while Reducing Medications in Patients With Heart Failure: A Case Series
IF 1.5 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Camille V. Owens, Rami S. Najjar, Marino A. Bruce, Bettina M. Beech, Baxter D. Montgomery
{"title":"A Defined, Plant-Based Diet and Other Integrative Therapies Improve Functional Status and Ejection Fraction while Reducing Medications in Patients With Heart Failure: A Case Series","authors":"Camille V. Owens, Rami S. Najjar, Marino A. Bruce, Bettina M. Beech, Baxter D. Montgomery","doi":"10.1177/15598276241281475","DOIUrl":null,"url":null,"abstract":"Heart failure with reduced ejection fraction (HFrEF) is a major contributor of premature cardiovascular-related deaths. Patients are typically on numerous medications to manage this condition; however, patients continue to experience poor quality of life. Alternative therapeutic approaches are needed to treat HFrEF. The clinical course of seven patients with Stage C and D HFrEF who failed guideline-directed medical therapy were retrospectively analyzed based on medical chart data. All patients consumed a defined, plant-based diet as part of their clinical treatment, and a subset also underwent alternative treatment modalities: External Counterpulsation therapy, BEMER therapy, infrared sauna therapy, ozone therapy, or PlaqueX® therapy. Chart review of these patients indicated improvement in left ventricular ejection fraction (LVEF) and right ventricular systolic pressure (RVSP). All patients also had a significant reduction in medication needs and body weight. Further, all patients reported significant improvements in their quality of life. These data suggest that a defined, plant-based diet combined with other alternative modalities may be efficacious in reducing HFrEF medications and treating Stage C or D HFrEF patients who failed guideline-direct medical therapies. Observations from this case series indicate a need for rigorous prospective studies to confirm these effects.","PeriodicalId":47480,"journal":{"name":"American Journal of Lifestyle Medicine","volume":"47 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Lifestyle Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15598276241281475","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Heart failure with reduced ejection fraction (HFrEF) is a major contributor of premature cardiovascular-related deaths. Patients are typically on numerous medications to manage this condition; however, patients continue to experience poor quality of life. Alternative therapeutic approaches are needed to treat HFrEF. The clinical course of seven patients with Stage C and D HFrEF who failed guideline-directed medical therapy were retrospectively analyzed based on medical chart data. All patients consumed a defined, plant-based diet as part of their clinical treatment, and a subset also underwent alternative treatment modalities: External Counterpulsation therapy, BEMER therapy, infrared sauna therapy, ozone therapy, or PlaqueX® therapy. Chart review of these patients indicated improvement in left ventricular ejection fraction (LVEF) and right ventricular systolic pressure (RVSP). All patients also had a significant reduction in medication needs and body weight. Further, all patients reported significant improvements in their quality of life. These data suggest that a defined, plant-based diet combined with other alternative modalities may be efficacious in reducing HFrEF medications and treating Stage C or D HFrEF patients who failed guideline-direct medical therapies. Observations from this case series indicate a need for rigorous prospective studies to confirm these effects.
射血分数降低性心力衰竭(HFrEF)是导致心血管相关性过早死亡的主要原因。患者通常需要服用多种药物来控制病情,但患者的生活质量仍然很差。我们需要其他治疗方法来治疗心房颤动缺氧(HFrEF)。我们根据病历数据回顾性分析了七名C期和D期HFrEF患者的临床病程,这些患者均未能接受指导性药物治疗。作为临床治疗的一部分,所有患者都摄入了明确的植物性饮食,部分患者还接受了其他治疗方式:此外,部分患者还接受了其他治疗方法:体外反搏疗法、BEMER疗法、红外线桑拿疗法、臭氧疗法或PlaqueX®疗法。对这些患者进行的病历审查显示,他们的左心室射血分数(LVEF)和右心室收缩压(RVSP)均有所改善。所有患者的用药需求和体重也都明显减少。此外,所有患者的生活质量都有明显改善。这些数据表明,明确的植物性饮食与其他替代方法相结合,可有效减少高心衰患者的用药量,并治疗指导性药物治疗失败的 C 期或 D 期高心衰患者。本系列病例的观察结果表明,需要进行严格的前瞻性研究来证实这些效果。